Ophthalmic Applications of lipid-based Drug nanocarriers: an Update of Research and Patenting Activity

References

• Davies NM . Biopharmaceutical considerations in topical ocular drug delivery. Clin. Exp. Pharmacol. Physiol.27, 558–562 (2000).
   PubMed Web of Science ®Google Scholar
• Zarbin MA Montemagno C Leary JF Ritch R . Nanomedicine in ophthalmology: the new frontier. Am. J. Ophthalmol.150, 144–162 (2010).
   PubMed Web of Science ®Google Scholar
• Pignatello R Puglisi G . Nanotechnology in ophthalmic drug delivery: a survey of recent developments and patenting activity. Recent Patents Nanomed.1 (1), 42–52 (2011).
   Google Scholar
• Almeida H Amaral MH Lobão P Silva AC Sousa Lobo JM . Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations. J. Pharm. Pharm. Sci.17 (3), 278–293 (2014).
   PubMed Web of Science ®Google Scholar
• Mishra GP Bagui M Tamboli V Mitra AK . Recent applications of liposomes in ophthalmic drug delivery. J. Drug Deliv.2011, 863734 (2011).
   PubMedGoogle Scholar
• Cholkar K Patel SP Vadlapudi AD Mitra AK . Novel strategies for anterior segment ocular drug delivery. J. Ocul. Pharmacol. Ther.29, 106–123 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou H-Y Hao J-L Wang S Zheng Y Zhang W-S . Nanoparticles in the ocular drug delivery. Int. J. Ophthalmol.6, 390–396 (2013).
   PubMed Web of Science ®Google Scholar
• Carbone C Musumeci T Lauro MR Puglisi G . Eco-friendly aqueous core surface-modified nanocapsules. Colloids Surf. B Biointerfaces125, 190–196 (2015).
   PubMed Web of Science ®Google Scholar
• Souto EB Müller RH . Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb. Exp. Pharmacol.197, 115–141 (2010).
   PubMedGoogle Scholar
• Fathi M Mozafari MR Mohebbi M . Nanoencapsulation of food ingredients using lipid based delivery systems. Trends Food Sci. Technol.23, 13–27 (2012).
   Web of Science ®Google Scholar
• Puglia C Bonina F . Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin. Drug Deliv.9 (4), 429–441 (2012).
   PubMed Web of Science ®Google Scholar
• Carbone C Cupri S Leonardi A Puglisi G Pignatello R . Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharm. Pat. Anal.2, 665–677 (2013).
   PubMedGoogle Scholar
• Souto EB Doktorovova S Gonzalez-Mira E Egea MA Garcia ML . Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr. Eye Res.35, 537–552 (2010).
   PubMed Web of Science ®Google Scholar
• Müller RH Mäder K Gohla S . Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur. J. Pharm. Biopharm.50, 161–177 (2000).
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodríguez A Delgado D Gascón AR Solinís MÁ . Lipid nanoparticles as drug/gene delivery systems to the retina. J. Ocul. Pharmacol. Ther.29 (2), 173–188 (2013).
   PubMed Web of Science ®Google Scholar
• Lallemand F Daull P Benita S Buggage R Garrigue JS . Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb. J. Drug Deliv.2012, 604204 (2012).
   PubMedGoogle Scholar
• Montenegro L Campisi A Sarpietro MG et al. In vitro valuation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug. Dev. Ind. Pharm.37 (6), 737–746 (2011).
   PubMed Web of Science ®Google Scholar
• Montenegro L Sinico C Castangia I Carbone C Puglisi G . Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: in vitro evaluation. Int. J. Pharm.434 (1–2), 169–174 (2012).
   PubMed Web of Science ®Google Scholar
• Müller RH Shegokar R Keck CM . 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr. Drug Discov. Technol.8 (3), 207–227 (2011).
   PubMedGoogle Scholar
• Shekunov BY Chattopadhyay P Tong HH Chow AH . Particle size analysis in pharmaceutics: principles, methods and applications. Pharm. Res.24 (2), 203–227 (2007).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E Egea MA Garcia ML Souto EB . Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf. B Biointerfaces81 (2), 412–421 (2010).
   PubMed Web of Science ®Google Scholar
• Puglia C Blasi P Rizza L et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm.357 (1–2), 295–304 (2008).
   PubMed Web of Science ®Google Scholar
• Puglia C Damiani E Offerta A et al. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies. Eur. J. Pharm. Sci.51, 211–217 (2014).
   PubMed Web of Science ®Google Scholar
• Bunjes HWK Kock MHJ . Crystallization tendency and polymorphic transitions in trigliceride nanoparticles. Int. J. Pharm.129, 159–173 (1996).
   Web of Science ®Google Scholar
• Freitas C Muller RH . Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm.47, 125–132 (1999).
   PubMed Web of Science ®Google Scholar
• Müller RH Radtke M Wissing SA . Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm.242, 121–128 (2002).
   PubMed Web of Science ®Google Scholar
• Carbone C Campisi A Musumeci T Raciti G Bonfanti R Puglisi G . FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur. J. Pharm. Sci.52, 12–20 (2014).
   PubMed Web of Science ®Google Scholar
• Huynh NT Passirani C Saulnier P Benoit JP . Lipid nanocapsules: a new platform for nanomedicine. Int. J. Pharm.379, 201–209 (2009).
   PubMed Web of Science ®Google Scholar
• Heurtault B Saulnier P Pech B Proust JE Benoit JP . A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res.19, 875–880 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas O Lagarce F . Lipid nanocapsules: a nanocarrier suitable for scale-up process. J. Drug Deliv. Sci. Tech.23, 555–559 (2013).
   Web of Science ®Google Scholar
• Müller RH Olbrich C . US6770299 (2004).
   Google Scholar
• Olbrich C Gessner A Kayser O Müller RH . Lipid–drug conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J. Drug Target.10, 387–396 (2002).
   PubMed Web of Science ®Google Scholar
• Paliwal R Rai S Vyas SP . Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J. Biomed. Nanotechnol.7, 130–131 (2011).
   PubMed Web of Science ®Google Scholar
• Araujo J Gonzales E Egea MA Garcia ML Souto EB . Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine5, 394–401 (2009).
   PubMed Web of Science ®Google Scholar
• Souza JG Karina D Pereira TA Bernardi DS Lopez RFV . Topical delivery of ocular therapeutics: carrier systems and physical methods. J. Pharm. Pharmacol.66, 507–530 (2013).
   PubMed Web of Science ®Google Scholar
• Sallam A Jayakumar S Lightman S . Intraocular delivery of anti-infective drugs-bacterial, viral, fungal and parasitic. Recent Pat. Antiinfect. Drug Discov.3, 53–63 (2008).
   PubMedGoogle Scholar
• Diebold Y Calonge M . Application on nanoparticles in ophthalmology. Prog. Retin. Eye Res.29, 596–609 (2010).
   PubMed Web of Science ®Google Scholar
• Anand R Nightingale SD Fish RH Smith TJ Ashton P . Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch. Ophthalmol.111, 223–227 (1993).
   PubMed Web of Science ®Google Scholar
• Yasukawa T Ogura Y Tabata Y Kimura H Wiedemann P Honda Y . Drug delivery systems for vitreoretinal diseases. Prog. Retin. Eye Res.23, 253–281 (2004).
   PubMed Web of Science ®Google Scholar
• Vandervoort J Ludwig A . Ocular drug delivery: nanomedicine applications. Nanomedicine2, 11–21 (2007).
   PubMed Web of Science ®Google Scholar
• Tian B-C Zhang W-J Xu H-M et al. Further investigation of nanostructured lipid carriers as an ocular delivery system: In vivo transcorneal mechanism and in vitro release study. Colloids Surf. B Biointerfaces102, 251–256 (2013).
   PubMed Web of Science ®Google Scholar
• Pretor S Bartels J Lorenz T et al. Cellular uptake of coumarin–6 under microfluidic conditions into HCE-T Cells from nanoscale formulations. Mol. Pharm.12 (1), 34–45 (2015).
   PubMedGoogle Scholar
• del Pozo-Rodriguez A Delgado D Solinis MA Gascon AR Pedraz JL . Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in retinal pigment epithelial cells. Int. J. Pharm.360 (1–2), 177–183 (2008).
   PubMedGoogle Scholar
• Apaolaza PS Delgado D del Pozo-Rodriguez A Gascon AR Solinis MA . A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases. Int. J. Pharm.465 (1–2), 413–426 (2014).
   PubMedGoogle Scholar
• Cupri S Bucolo C Romano GL et al. New nanotechnology formulations for HuR siRNA delivery to the retina. Presented at : XXIII National Meeting in Medicinal Chemistry (NMMC2015). Salerno, Italy, 6–9 September 2015.
   Google Scholar
• Amadio M Bucolo C Govoni S et al. Oligonucleotides against VEGF overexpression–between realty and potentiality Presented at : European Association for Vision and Eye Research Annual Congress (EVER 2015). Nice, France, 7–10 October 2015.
   Google Scholar
• Youshia J Kamel AO El Shamy A Mansour S . Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide. Int. J. Nanomedicine7, 2483–2496 (2012).
   PubMed Web of Science ®Google Scholar
• Wang F Chen L Jiang S et al. Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design. J. Liposome Res.24 (3), 171–181 (2014).
   PubMed Web of Science ®Google Scholar
• Wang F Chen L Zhang D et al. Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: in vitro and in vivo study. J. Drug Target.22 (9), 849–858 (2014).
   PubMed Web of Science ®Google Scholar
• Li R Xu E Fengzhen W Qing Z Min JS Hongliang X . CN 102793672 A (2012).
   Google Scholar
• Luetfi G Muezeyyen D . Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application. Pharm. Dev. Tech.18 (3), 701–709 (2013).
   PubMed Web of Science ®Google Scholar
• Attama AA Reichl S Mueller-Goymann CC . Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Curr. Eye Res.34 (8), 698–705 (2009).
   PubMed Web of Science ®Google Scholar
• Leonardi A Bucolo C Drago F Salomone S Pignatello R . Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. Int. J. Pharm.478, 180–186 (2014).
   PubMedGoogle Scholar
• Araújo J Gonzalez-Mira E Egea MA Garcia ML Souto EB . Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm.393 (1–2), 167–175 (2010).
   PubMed Web of Science ®Google Scholar
• Araújo J Nikolic S Egea MA Souto EB Garcia ML . Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf. B88, 150–157 (2011).
   PubMed Web of Science ®Google Scholar
• Araújo J Garcia ML Mallandrich M Souto EB Calpena AC . Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies. Nanomedicine8, 1034–1041 (2012).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E Egea MA Souto EB Calpena AC García ML . Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology22, 045101 (2011).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E Nikolić S Calpena AC Egea MA Souto EB García ML . Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels. J. Pharm. Sci.101, 707–725 (2012).
   PubMed Web of Science ®Google Scholar
• Luo Q Zhao J Zhang X Pan W . Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharm.403, 185–191 (2011).
   PubMed Web of Science ®Google Scholar
• Tian B Luo Q Song S et al. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J. Pharm. Sci.101, 1040–1049 (2012).
   PubMed Web of Science ®Google Scholar
• Hippalgaonkar K Adelli GR Hippalgaonkar K Repka MA Majumdar S . Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J. Ocul. Pharmacol. Ther.29, 216–228 (2013).
   PubMed Web of Science ®Google Scholar
• Attama AA Reichl S Müller-Goymann CC . Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int. J. Pharm.355, 307–313 (2008).
   PubMed Web of Science ®Google Scholar
• Li X Nie SF Kong J Li N Ju CY Pan WS . A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm.363 (1–2), 177–182 (2008).
   PubMedGoogle Scholar
• Abul Kalam M Sultana Y Ali A et al. Part I: development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. J. Biomed. Mater. Res. A101, 813–827 (2013).
   Web of Science ®Google Scholar
• Abul Kalam M Sultana Y Ali A et al. Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J. Biomed. Mater. Res. A101 (6), 1828–1836 (2013).
   PubMed Web of Science ®Google Scholar
• Abul Kalam M Sultana Y Ali A Aqil M Mishra AK Chuttani K . Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J. Drug Target.18, 191–204 (2010).
   PubMed Web of Science ®Google Scholar
• Hao J Fang X Zhou Y et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int. J. Nanomedicine6, 683–692 (2011).
   PubMed Web of Science ®Google Scholar
• Wu JW Xia Q . Preparation and characterization of azithromycin-loaded nanostructured lipid carriers. Adv. Mater. Res.236–238 (2011).
   Google Scholar
• Ustündağ-Okur N Gökçe EH Bozbıyık Dİ Eğrilmez S Ozer O Ertan G . Preparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nanostructured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur. J. Pharm. Sci.63, 204–215 (2014).
   PubMed Web of Science ®Google Scholar
• Verma SR Doshi A . Formulation development and characterization of nanostructured heterolipid matrix of levofloxacin hemihydrate for ocular drug delivery. J. Pharmacol. Clin. Toxicol.2 (3), 1035 (2014).
   Google Scholar
• Law SL Huang KJ Chiang CH . Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J. Control. Release63, 135–140 (2000).
   PubMed Web of Science ®Google Scholar
• de Jalòn EG Blanco-Prìeto MJ Ygartua P Santoyo S . Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type I in cell cultures. Eur. J. Pharm. Biopharm.53, 183–187 (2003).
   Google Scholar
• Vadlapudi AD Vadlapatla RK Kwatra D et al. Targeted lipid based drug conjugates: a novel strategy for drug delivery. Int. J. Pharm.434 (1–2), 315–324 (2012).
   PubMed Web of Science ®Google Scholar
• Seyfoddin A Al-Kassas R . Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev. Ind. Pharm.39 (4), 508–519 (2013).
   PubMed Web of Science ®Google Scholar
• Gokce EH Sandri G Bonferoni MC et al. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int. J. Pharm.364, 76–86 (2008).
   PubMed Web of Science ®Google Scholar
• Niu M Shi K Sun Y Wang J Cui F . Preparation of CsA-loaded solid lipid nanoparticles and application on ocular preparations. J. Drug Deliv. Sci. Tech.18, 293–297 (2008).
   Web of Science ®Google Scholar
• Gokce EH Sandri G Egrilmez S Bonferoni MC Gueneri T Caramella C . Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. Curr. Eye Res.34, 996–1003 (2009).
   PubMed Web of Science ®Google Scholar
• Sandri G Bonferoni MC Gokce EH et al. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J. Microencapsul.27, 735–746 (2010).
   PubMed Web of Science ®Google Scholar
• Basaran E Demirel M Sirmagul B Yazan Y . Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J. Microencapsul.27, 37–47 (2010).
   PubMed Web of Science ®Google Scholar
• Shen J Deng Y Jin X Ping Q Su Z Li L . Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int. J. Pharm.402, 248–253 (2010).
   PubMed Web of Science ®Google Scholar
• Battaglia L D'Addino I Peira E Trotta M Gallarate M . Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine. J. Drug Deliv. Sci. Tech.22, 125–130 (2012).
   Web of Science ®Google Scholar
• Zhang W Li X Ye T et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Int. J. Pharm.454, 354–366 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang W Liu J Zhang Q et al. Enhanced cellular uptake and anti-proliferating effect of chitosan hydrochlorides modified genistein loaded NLC on human lens epithelial cells. Int. J. Pharm.471, 118–126 (2014).
   PubMed Web of Science ®Google Scholar
• Strettoi E Gargini C Novelli E et al. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc. Natl Acad. Sci. USA107, 18706–18711 (2010).
   PubMed Web of Science ®Google Scholar
• Liu R Liu Z Zhang C Zhang B . Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. J. Pharm. Sci.101 (10), 3833–3844 (2012).
   PubMed Web of Science ®Google Scholar
• Liu Z Zhang X Wu H et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev. Ind. Pharm.37 (4), 475–481 (2011).
   PubMed Web of Science ®Google Scholar
• Hao J Wang X Bi Y et al. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Colloids Surf. B Biointerfaces114, 111–120 (2014).
   PubMed Web of Science ®Google Scholar
• Li J Guo X Liu Z et al. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev. Ind. Pharm.40 (7), 980–987 (2014).
   PubMed Web of Science ®Google Scholar
• Liu C-H Chiu H-C Wu W-C Sahoo SL Hsu C-Y . Novel lutein loaded lipid nanoparticles on porcine corneal distribution. J. Ophthalmol.2014, 304694 (2014).
   PubMed Web of Science ®Google Scholar
• Jiang M Gan L Zhu C Dong Y Liu J Gan Y . Cationic core-shell liponanoparticles for ocular gene delivery. Biomaterials33 (30), 7621–7630 (2012).
   PubMed Web of Science ®Google Scholar
• Delgado D del Pozo-Rodriguez A Solinis MA Rodriguez-Gascon A . Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway. Eur. J. Pharm. Biopharm.79 (3), 495–502 (2011).
   PubMed Web of Science ®Google Scholar
• Almeida DR Johnson D Hollands H et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J. Cataract Refr. Surg.34, 64–69 (2008).
   PubMed Web of Science ®Google Scholar
• Sengupta S Subramoney K Srinivasan R et al. Use of a mydriatic cocktail with a wick for preoperative mydriasis in cataract surgery: a prospective randomised controlled trial. Eye (Lond.)24, 118–122 (2010).
   PubMedGoogle Scholar
• Bucolo C Maltese A Puglisi G Pignatello R . Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension. Ophthalmic Res.34, 319–323 (2002).
   PubMed Web of Science ®Google Scholar
• Chetoni P Panichi L Burgalassi S Benelli U Saettone MF . Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. J. Ocul. Pharmacol. Ther.16 (4), 363–372 (2000).
   PubMed Web of Science ®Google Scholar
• Pignatello R Bucolo C Spedalieri G Maltese A Puglisi G . Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials23, 3247–3255 (2002).
   PubMed Web of Science ®Google Scholar
• Shaikh MY Mars JS Heaven CJ . Prednisolone and flurbiprofen drops to maintain mydriasis during phacoemulsification cataract surgery. J. Cataract Refract. Surg.29, 2372–2377 (2003).
   PubMed Web of Science ®Google Scholar
• Scott IU Flynn HW Jr Rosenfeld PJ . Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am. J. Ophthalmol.136, 737–739 (2003).
   PubMed Web of Science ®Google Scholar
• Suresh PK Sah AK . Patent perspectives for corticosteroids based ophthalmic therapeutics. Recent Pat. Drug Deliv. Formul.8 (3), 206–223 (2014).
   PubMedGoogle Scholar
• Felt-Baeyens O Eperon S Mora P et al. Biodegradable scleral implants as new triamcinolone acetonide delivery systems. Int. J. Pharm.322, 6–12 (2006).
   PubMed Web of Science ®Google Scholar
• Shen J Sun M Ping Q Ying Z Liu W . Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology21, 025101/1–025101/10 (2010).
   Web of Science ®Google Scholar
• Carbone C Tomasello B Ruozi B Renis M Puglisi G . Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. Eur. J. Med. Chem.49, 110–117 (2012).
   PubMed Web of Science ®Google Scholar
• Carbone C Campisi A Manno D et al. The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC. Colloids Surf. B Biointerfaces121, 1–10 (2014).
   PubMed Web of Science ®Google Scholar
• Leonardi A Crascì L Panico A Pignatello R . Antioxidant activity of idebenone-loaded neutral and cationic solid-lipid nanoparticles. Pharm. Dev. Technol.20 (6), 716–723 (2014).
   PubMed Web of Science ®Google Scholar
• Fangueiro JF Andreani T Egea MA et al. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity. Int. J. Pharm.461 (1–2), 64–73 (2014).
   PubMedGoogle Scholar
• Shen J Wang Y Ping Q Xiao Y Huang X . Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J. Control. Release137, 217–223 (2009).
   PubMed Web of Science ®Google Scholar
• Mohanty B Majumdar DK Mishra SK Panda AK Patnaik S . Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm. Dev. Technol.20 (4), 458–464 (2015).
   PubMed Web of Science ®Google Scholar
• Pignatello R Leonardi A Cupri S . Optimization and validation of a new method for the production of lipid nanoparticles for ophthalmic application. Int. J. Med. Nano Res.1, 006 (2014).
   Google Scholar
• Amadio M Bucolo C Leggio GM Drago F Govoni S Pascale A . The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem. Pharmacol.80 (8), 1230–1237 (2010).
   PubMed Web of Science ®Google Scholar
• Spalton DJ . Posterior capsular opacification after cataract surgery. Eye (Lond.)13, 489–492 (1999).
   PubMed Web of Science ®Google Scholar
• Walker JL Wolff IM Zhang L Menko AS . Activation of SRC kinases signals induction of posterior capsule opacification. Invest Ophthalmol. Vis. Sci.48 (5), 2214–2223 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang W Li X Ye T et al. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions. Int. J. Nanomed.9, 4305–4315 (2014).
   PubMed Web of Science ®Google Scholar
• Gupta D Bleakley B Gupta RK . Dragon's blood: botany, chemistry and therapeutic uses. J. Ethnopharmacol.115, 361–380 (2008).
   PubMed Web of Science ®Google Scholar
• Hartong DT Berson EL Dryja TP . Retinitis pigmentosa. Lancet368, 1795–1809 (2006).
   PubMed Web of Science ®Google Scholar
• Rotstein NP Miranda GE Abrahan CE German OL . Regulating survival and development in the retina: key roles for simple sphingolipids. J. Lipid Res.51, 1247–1262 (2010).
   PubMed Web of Science ®Google Scholar
• Kitano A Yamanaka O Ikeda K et al. Tetrandrine suppresses activation of human subconjunctival fibroblasts in vitro. Curr. Eye Res.33 (7), 559–565 (2008).
   PubMed Web of Science ®Google Scholar
• Carbone C Leonardi A Cupri S Puglisi G Pignatello R . Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharm. Pat. Anal.3 (2), 199–215 (2014).
   PubMedGoogle Scholar
• Chen T Vargeese C Vagle K Wang W Zhang Y . WO086883 (2007).
   Google Scholar
• Hartman GD Vargeese C Wang W . WO080724 (2010).
   Google Scholar
• Bowman KA Guare JP Hartman GD et al. WO021865 (2010).
   Google Scholar
• De Almeida Moreira Sereno JN et al. WO 2011119058 (2012).
   Google Scholar
• Nazzal SM Sylvester PW . WO028757 (2011).
   Google Scholar
• Del Pozo Rodriguez A et al. WO085318 (2012).
   Google Scholar
• Fu-de C Meng Meng N . CN101181227 (2012).
   Google Scholar
• Guild BC Derosa F . WO170930 (2012).
   Google Scholar
• de Fougerolles A Wood KM Elbashir SM Schrum JP . WO090648 (2013).
   Google Scholar
• Lee RJ Lee YB Kim DJ . WO177419 (2013).
   Google Scholar
• Kaur IP Verma MK . WO105026 (2013).
   Google Scholar
• Qi M Yang B Geng H Yu Y . CN 103989660A (2014).
   Google Scholar
• Schmidt MM Kovalchin JT Furfine ES Celniker AC Erbe DV . WO107737 (2014).
   Google Scholar
• Olbrich C Muller RH . Enzymatic degradation of SLN–effect of surfactant and surfactant mixtures. Int. J. Pharm.180, 31–39 (1999).
   PubMed Web of Science ®Google Scholar
• Uner M Wissing SA Yener G Müller RH . Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations. Pharmazie59, 331–332 (2004).
   PubMed Web of Science ®Google Scholar
• Leonardi A Bucolo C Romano GL et al. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. Int. J. Pharm.470, 133–140 (2014).
   PubMed Web of Science ®Google Scholar
• Hwang TL Aljuffali IA Lin CF Chang YT Fang JY . Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles. Int. J. Nanomedicine10, 371–385 (2015).
   PubMed Web of Science ®Google Scholar
• Prow TW . Toxicity of nanomaterials to the eye. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.2, 317–333 (2010).
   PubMed Web of Science ®Google Scholar
• Grover A Hirani A Lee YW Sutariya VB Pathak Y . Ocular toxicity of nanoparticles. In : Biointeractions of Nanomaterials. SutariyaVBPathakY ( Eds). CRS Press, Boca Raton, FL, USA, 347–352 (2015).
   Google Scholar
• US FDA . www.fda.gov/scienceresearch/specialtopics/nanotechnology/ucm2006658.htm.
   Google Scholar
• Ophthalmology Drugs & Devices Market . www.marketsandmarkets.com.
   Google Scholar